Cyclo Therapeutics

Developer of therapeutics for Niemann-Pick Disease Type C and Alzheimer’s Disease

placeNew York, New York, United States calendar_todayFounded 1990 groups9 employees language cyclotherapeutics.com

Registered entities

Social engagement

Social engagement: 2.7K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

3 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital133%
Private equity133%
Bank & private debt133%

Recent activity

30 Jun 2026
Event
NATIONAL NIEMANN-PICK DISEASE FOUNDATION Family Support and Medical Conference
10 Jun 2026
Milestone
22 Apr 2026
Partnership
Massachusetts Institute of Technology
Coming soon